Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Cell Transfection Market Expected To Reach $2.17 Billion By 2030 At 8.9% CAGR

The market for cell transfection witnessed robust expansion recently, projected to climb from $1.42 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 9.2%. This surge in demand during the past period is linked to several key factors, including the broadening scope of molecular biology research, a greater reliance on gene expression studies, advancements in recombinant protein production, the escalating application of in vitro genetic manipulation techniques, and the availability of a wide array of transfection methodologies.

The cell transfection market is poised for substantial expansion over the coming years, projecting a valuation of $2.17 billion by 2030, driven by an 8.9% compound annual growth rate. This anticipated growth trajectory is fueled by several key factors, including the burgeoning development of gene and cell therapies, increased financial commitment to genetic engineering research, a heightened demand for high-throughput screening methodologies, the broadening scope of personalized medicine initiatives, and the expanding utilization of non-viral delivery systems. Several significant trends are expected to shape this market during the forecast period, such as a greater embrace of highly effective transfection reagents, a rise in the application of viral vector-based transfection techniques, burgeoning demand for transfection methods that can be scaled up, the proliferation of automated transfection platforms, and a heightened emphasis on ensuring the reproducibility of transfection processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Cell Transfection Market Industry Drivers: What Is Driving Revenue Growth?

The rising incidence of infectious diseases is anticipated to significantly boost the cell transfection market’s expansion. Infectious diseases, characterized by their transmission through various means, have seen an upsurge due to factors like underdeveloped public health systems, vaccine reluctance, and the proliferation of false information, which collectively enable pathogen dissemination and mutation. Cell transfection serves as an invaluable method in combating infectious diseases by enabling researchers to introduce genetic material into cells for the purpose of understanding infection mechanisms and evaluating novel therapeutic strategies. For example, as reported by the World Health Organization, a global public health entity based in Switzerland, approximately 8.2 million new tuberculosis diagnoses occurred in 2023, an increase from the roughly 7.5 million cases identified in 2022, underscoring tuberculosis’s position as the foremost cause of infectious disease mortality. Consequently, the escalating prevalence of infectious diseases is a key driver for the cell transfection market.

Cell Transfection Market Segmentation And Category Breakdown

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

#Cell Transfection Market Growth Trends: What Is Influencing The Future Outlook?

Leading entities within the cell transfection sector are actively incorporating novel advancements into their transfection methodologies to facilitate meticulous regulation of genetic expression. Essentially, a transfection system represents a method or apparatus developed for the purpose of inserting exogenous nucleic acids into cellular structures, thereby facilitating the investigation of gene roles, the synthesis of proteins, or the modification of gene activity. As an illustration, during July of 2024, STEMCELL Technologies, a prominent biotechnology firm headquartered in Canada, introduced its Cellpore transfection system. This innovative instrument is engineered to bolster research endeavors in cell engineering. Leveraging cutting-edge microfluidic technology, the system streamlines the intracellular introduction of a wide spectrum of macromolecules into cells, effectively overcoming the shortcomings inherent in conventional transfection approaches. Its capacity to transfect as many as ten million cells each second renders it highly advantageous for operations requiring significant throughput. Furthermore, the system demonstrates versatility across a range of cell populations, including but not limited to T cells and hematopoietic stem cells. It possesses the capability to deliver a variety of payload types, encompassing small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Cell Transfection Market Competitive Analysis Of Major Industry Participants

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Access The Complete Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Cell Transfection Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the cell transfection market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model